XML 34 R24.htm IDEA: XBRL DOCUMENT v3.21.2

Acquisitions (Tables)

9 Months Ended

Sep. 30, 2021

Avitide, Inc.

Schedule of Business Combination Consideration Transferred

Total consideration transferred is as follows (amounts in thousands):

Cash consideration		$	75,004
Equity consideration			77,576
Contingent consideration - earnout			79,962
Fair value of net assets acquired		$	232,542

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

The components and estimated allocation of the purchase price consist of the following (amounts in thousands):

Cash and cash equivalents		$	572
Accounts receivable			228
Inventory			400
Prepaid expenses and other current assets			114
Property and equipment			1,862
Operating lease right of use asset			2,459
Customer relationships			23,310
Developed technology			19,610
Trademark and tradename			1,150
Non-competition agreements			200
Goodwill			193,463
Accounts payable			(215		)
Accrued liabilities			(2,183		)
Operating lease liability			(782		)
Operating lease liability, long-term			(1,606		)
Long term deferred tax liability			(5,982		)
Other liabilities			(58		)
Fair value of net assets acquired		$	232,542

Schedule of Identified Intangible Assets and Estimated Useful Lives

The following table sets forth the components of the identified intangible assets associated with the Avitide Acquisition and their estimated useful lives:

		Useful life		Fair Value
				(Amounts in thousands)
Customer relationships		13 years		$	23,310
Developed technology		15 years			19,610
Trademark and tradename		18 years			1,150
Non-competition agreements		3 years			200
				$	44,270

Polymem S.A.

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

The components and estimated allocation of the purchase price consist of the following (amounts in thousands):

Cash and cash equivalents		$	353
Net working capital (excluding cash and inventory      step-up)			375
Inventory step-up			543
Operating lease right of use assets			1,424
Property and equipment			3,145
Other assets			41
Customer relationships			17,234
Developed technology			7,545
Trademark and tradenames			557
Non-compete agreements			344
Goodwill			23,453
Operating lease liability			(1,253	)
Long term deferred tax liability			(6,646	)
Other long-term liabilities			(142	)
Fair value of net assets acquired		$	46,973

Schedule of Identified Intangible Assets and Estimated Useful Lives

The following table sets forth the components of the identified intangible assets associated with the Polymem Acquisition and their estimated useful lives:

		Useful life		Fair Value
				(Amounts in thousands)
Customer relationships		14 years		$	17,234
Developed technology		13 years			7,545
Trademark and tradename		14 years			557
Non-competition agreements		5 years			344
				$	25,680

ARTeSYN Biosolutions

Schedule of Business Combination Consideration Transferred

Total consideration transferred is as follows (amounts in thousands):

Cash consideration		$	130,713
Equity consideration			69,422
Contingent consideration			1,548
Settlement of preexisting liabilities			2,310
Fair value of net assets acquired		$	203,993

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

The components and estimated allocation of the purchase price consist of the following (amounts in thousands):

Cash and cash equivalents		$	2,982
Accounts receivable			4,811
Inventory			8,592
Prepaid expenses and other current assets			5,561
Property and equipment			1,836
Operating lease right of use asset			1,611
Other noncurrent assets			26
Customer relationships			38,400
Developed technology			27,060
Trademark and tradename			1,630
Non-competition agreements			300
Goodwill			128,598
Accounts payable			(2,251	)
Accrued liabilities			(8,706	)
Deferred revenue			(3,583	)
Deferred tax liabilities, net			(1,240	)
Notes payable			(24	)
Operating lease liability			(417	)
Operating lease liability, long-term			(1,193	)
Fair value of net assets acquired		$	203,993

Schedule of Identified Intangible Assets and Estimated Useful Lives

The following table sets forth the components of the identified intangible assets associated with the ARTeSYN Acquisition and their estimated useful lives:

		Useful life		Fair Value
				(Amounts in thousands)
Customer relationships		17 years		$	38,400
Developed technology		15 years			27,060
Trademark and tradename		21 years			1,630
Non-competition agreements		3 years			300
				$	67,390

Non Metallic Solutions

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

The components and allocation of the purchase price consist of the following (amounts in thousands):

Cash and cash equivalents		$	1,163
Accounts receivable			415
Inventory			334
Prepaid expenses and other current assets			13
Property and equipment			73
Operating lease right of use asset			194
Customer relationships			6,370
Developed technology			1,810
Trademark and tradename			190
Non-competition agreements			90
Goodwill			6,713
Deferred tax assets			24
Accounts payable			(96		)
Accrued liabilities			(999		)
Operating lease liability			(136		)
Operating lease liability, long-term			(59		)
Fair value of net assets acquired		$	16,099

Schedule of Identified Intangible Assets and Estimated Useful Lives

The following table sets forth the components of the identified intangible assets associated with the NMS Acquisition and their estimated useful lives:

		Useful life		Fair Value
				(Amounts in thousands)
Customer relationships		14 years		$	6,370
Developed technology		12 years			1,810
Trademark and tradename		15 years			190
Non-competition agreements		3 years			90
				$	8,460

X

- Definition

Tabular disclosure of business combination consideration transferred.

+ References

No definition available.

+ Details

Name:	rgen_ScheduleOfBusinessCombinationConsiderationTransferredTableTextBlock
Namespace Prefix:	rgen_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of finite-lived intangible assets acquired as part of a business combination or through an asset purchase, by major class and in total, including the value of the asset acquired, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275

+ Details

Name:	us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472

+ Details

Name:	us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	us-gaap_BusinessAcquisitionAxis=rgen_AvitideIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_BusinessAcquisitionAxis=rgen_PolymemSAMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_BusinessAcquisitionAxis=rgen_ArtesynBiosolutionsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_BusinessAcquisitionAxis=rgen_NonMetallicSolutionsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: